Rani Therapeutics 13D Filing
Rani Therapeutics Holdings, Inc. files amended Schedule 13D with the SEC. The filing indicates a change in beneficial ownership.
Filed: 2026-05-28 AccNo: 0001699737-26-000014 Size: 15 KB
Rani Therapeutics Holdings, Inc. files amended Schedule 13D with the SEC. The filing indicates a change in beneficial ownership.
Filed: 2026-05-28 AccNo: 0001699737-26-000014 Size: 15 KB